Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared wit...
Gespeichert in:
| Veröffentlicht in: | Global health science and practice 2017-12, Vol.5 (4), p.534-539 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 539 |
|---|---|
| container_issue | 4 |
| container_start_page | 534 |
| container_title | Global health science and practice |
| container_volume | 5 |
| creator | Ali, Moazzam Bahamondes, Luis Bent Landoulsi, Sihem |
| description | Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).
Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label). |
| doi_str_mv | 10.9745/GHSP-D-17-00296 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5752601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1979522547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2386-62ecaa86aade1b9d85b2638feb8a2afaf25fdf3e5016d1aef0a45abc5254aed53</originalsourceid><addsrcrecordid>eNplks1uEzEUhUcIRKvSNTvkJZtJx554fjZIJUnbSJGoCJVgZd0ZX6dGM3awPVHzYLwA6z5UPWmpivDGlnzOd-1zb5K8p9mkLqf87PJqfZ3OU1qmWcbq4lVyzGhRp7zk31-_OB8lp97_zOKqp5TV1dvkiNWsyDPGj5P7xV1AI1GShVLYBr1Dg94Tq0i4RbII1tgN-uCwS79ih-C12ZCZNcFBi9tRT5b9tgMTCBh5MLGM_Pm9ISvcRbP7370czUNApw2S9d4H7ImyjjDyA8F58hn3NqJuJusJubBWHsBzN2zIuey10ZEHQVtDrp2VQxvIChrsIvld8kZB5_H0aT9Jbi4W32ZX6erL5XJ2vkpblldFWjBsAaoCQCJtalnxJsZRKWwqYKBAMa6kypFntJAUUGUw5dC0nPEpoOT5SfLpkbsdmh5li-OHOrF1uge3Fxa0-PfG6FuxsTsR28GKjEbAxyeAs7-GGJDotW-xizGiHbygdVlzFsuVUXr2KG2d9d6hei5DMzGOgRjHQMwFLcVhDKLjw8vXPev_Nj1_AK-mtYg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1979522547</pqid></control><display><type>article</type><title>Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ali, Moazzam ; Bahamondes, Luis ; Bent Landoulsi, Sihem</creator><creatorcontrib>Ali, Moazzam ; Bahamondes, Luis ; Bent Landoulsi, Sihem</creatorcontrib><description>Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).
Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).</description><identifier>ISSN: 2169-575X</identifier><identifier>EISSN: 2169-575X</identifier><identifier>DOI: 10.9745/GHSP-D-17-00296</identifier><identifier>PMID: 29263025</identifier><language>eng</language><publisher>United States: Global Health: Science and Practice</publisher><subject>Contraceptive Agents, Female - administration & dosage ; Contraceptive Agents, Female - pharmacology ; Desogestrel - administration & dosage ; Desogestrel - pharmacology ; Drug Implants ; Female ; Humans ; Intrauterine Devices, Medicated ; Levonorgestrel - administration & dosage ; Levonorgestrel - pharmacology ; Product Labeling ; Randomized Controlled Trials as Topic ; Time Factors ; United States ; United States Food and Drug Administration</subject><ispartof>Global health science and practice, 2017-12, Vol.5 (4), p.534-539</ispartof><rights>Ali et al. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2386-62ecaa86aade1b9d85b2638feb8a2afaf25fdf3e5016d1aef0a45abc5254aed53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752601/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752601/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29263025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ali, Moazzam</creatorcontrib><creatorcontrib>Bahamondes, Luis</creatorcontrib><creatorcontrib>Bent Landoulsi, Sihem</creatorcontrib><title>Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling</title><title>Global health science and practice</title><addtitle>Glob Health Sci Pract</addtitle><description>Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).
Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).</description><subject>Contraceptive Agents, Female - administration & dosage</subject><subject>Contraceptive Agents, Female - pharmacology</subject><subject>Desogestrel - administration & dosage</subject><subject>Desogestrel - pharmacology</subject><subject>Drug Implants</subject><subject>Female</subject><subject>Humans</subject><subject>Intrauterine Devices, Medicated</subject><subject>Levonorgestrel - administration & dosage</subject><subject>Levonorgestrel - pharmacology</subject><subject>Product Labeling</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Time Factors</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>2169-575X</issn><issn>2169-575X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplks1uEzEUhUcIRKvSNTvkJZtJx554fjZIJUnbSJGoCJVgZd0ZX6dGM3awPVHzYLwA6z5UPWmpivDGlnzOd-1zb5K8p9mkLqf87PJqfZ3OU1qmWcbq4lVyzGhRp7zk31-_OB8lp97_zOKqp5TV1dvkiNWsyDPGj5P7xV1AI1GShVLYBr1Dg94Tq0i4RbII1tgN-uCwS79ih-C12ZCZNcFBi9tRT5b9tgMTCBh5MLGM_Pm9ISvcRbP7370czUNApw2S9d4H7ImyjjDyA8F58hn3NqJuJusJubBWHsBzN2zIuey10ZEHQVtDrp2VQxvIChrsIvld8kZB5_H0aT9Jbi4W32ZX6erL5XJ2vkpblldFWjBsAaoCQCJtalnxJsZRKWwqYKBAMa6kypFntJAUUGUw5dC0nPEpoOT5SfLpkbsdmh5li-OHOrF1uge3Fxa0-PfG6FuxsTsR28GKjEbAxyeAs7-GGJDotW-xizGiHbygdVlzFsuVUXr2KG2d9d6hei5DMzGOgRjHQMwFLcVhDKLjw8vXPev_Nj1_AK-mtYg</recordid><startdate>20171228</startdate><enddate>20171228</enddate><creator>Ali, Moazzam</creator><creator>Bahamondes, Luis</creator><creator>Bent Landoulsi, Sihem</creator><general>Global Health: Science and Practice</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171228</creationdate><title>Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling</title><author>Ali, Moazzam ; Bahamondes, Luis ; Bent Landoulsi, Sihem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2386-62ecaa86aade1b9d85b2638feb8a2afaf25fdf3e5016d1aef0a45abc5254aed53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Contraceptive Agents, Female - administration & dosage</topic><topic>Contraceptive Agents, Female - pharmacology</topic><topic>Desogestrel - administration & dosage</topic><topic>Desogestrel - pharmacology</topic><topic>Drug Implants</topic><topic>Female</topic><topic>Humans</topic><topic>Intrauterine Devices, Medicated</topic><topic>Levonorgestrel - administration & dosage</topic><topic>Levonorgestrel - pharmacology</topic><topic>Product Labeling</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Time Factors</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ali, Moazzam</creatorcontrib><creatorcontrib>Bahamondes, Luis</creatorcontrib><creatorcontrib>Bent Landoulsi, Sihem</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Global health science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ali, Moazzam</au><au>Bahamondes, Luis</au><au>Bent Landoulsi, Sihem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling</atitle><jtitle>Global health science and practice</jtitle><addtitle>Glob Health Sci Pract</addtitle><date>2017-12-28</date><risdate>2017</risdate><volume>5</volume><issue>4</issue><spage>534</spage><epage>539</epage><pages>534-539</pages><issn>2169-575X</issn><eissn>2169-575X</eissn><abstract>Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).
Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).</abstract><cop>United States</cop><pub>Global Health: Science and Practice</pub><pmid>29263025</pmid><doi>10.9745/GHSP-D-17-00296</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2169-575X |
| ispartof | Global health science and practice, 2017-12, Vol.5 (4), p.534-539 |
| issn | 2169-575X 2169-575X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5752601 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Contraceptive Agents, Female - administration & dosage Contraceptive Agents, Female - pharmacology Desogestrel - administration & dosage Desogestrel - pharmacology Drug Implants Female Humans Intrauterine Devices, Medicated Levonorgestrel - administration & dosage Levonorgestrel - pharmacology Product Labeling Randomized Controlled Trials as Topic Time Factors United States United States Food and Drug Administration |
| title | Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T18%3A16%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extended%20Effectiveness%20of%20the%20Etonogestrel-Releasing%20Contraceptive%20Implant%20and%20the%2020%20%C2%B5g%20Levonorgestrel-Releasing%20Intrauterine%20System%20for%202%20Years%20Beyond%20U.S.%20Food%20and%20Drug%20Administration%20Product%20Labeling&rft.jtitle=Global%20health%20science%20and%20practice&rft.au=Ali,%20Moazzam&rft.date=2017-12-28&rft.volume=5&rft.issue=4&rft.spage=534&rft.epage=539&rft.pages=534-539&rft.issn=2169-575X&rft.eissn=2169-575X&rft_id=info:doi/10.9745/GHSP-D-17-00296&rft_dat=%3Cproquest_pubme%3E1979522547%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1979522547&rft_id=info:pmid/29263025&rfr_iscdi=true |